会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Anesthetic composition for intravenous injection comprising propofol
    • 用于静脉内注射的麻醉组合物包含异丙酚
    • US06743436B1
    • 2004-06-01
    • US10018663
    • 2001-12-21
    • Hyuk-Koo LeeJi-Young JinHoon Cho
    • Hyuk-Koo LeeJi-Young JinHoon Cho
    • A61F202
    • A61K9/1075A61K31/05
    • An anesthetic composition for intravenous injection, comprising propofol (2,6-diisopropylphenol) and Poloxamer POLOXAMER (Polyoxyethylene-polyoxypropylene copolymer) as surfactant is disclosed. The composition optionally can contain at least one co-surfactant selected from the group consisting of SOLUTOL HS 15 (Macrogol-15 Hydroxystearate), egg lecithin, LABRASOL (Polyoxy capryllic glyceride), polyoxy 10-oleyl-ether, TWEEN (polyoxyethylene sorbitan fatty acid esters), ethanol and polyethylene glycol. Because the composition is usually prepared in the form of an oil-in-water microemulsion having a particle size of 100 nm and below, it has superior technical effects in that it is thermodynamically stable and can be aseptically filtered to prevent microorganism contamination. Moreover, the composition is readily prepared so that side effects such as embolism, hyperlipidemia, etc. can be minimized.
    • 公开了一种用于静脉注射的麻醉组合物,其包含异丙酚(2,6-二异丙基苯酚)和泊洛沙姆POLOXAMER(聚氧乙烯 - 聚氧丙烯共聚物)作为表面活性剂。 组合物任选地可以含有至少一种选自SOLUTOL HS 15(Macrogol-15羟基硬脂酸酯),卵磷脂,LABRASOL(聚氧丙烯酸甘油酯),聚氧十油基醚,TWEEN(聚氧乙烯脱水山梨糖醇脂肪酸 酯),乙醇和聚乙二醇。 由于该组合物通常以粒径为100nm以下的水包油微乳液的形式制备,所以具有优异的技术效果,因为其具有热力学稳定性,可无菌过滤以防止微生物污染。 此外,容易制备组合物,使得可以使诸如栓塞,高脂血症等的副作用最小化。